33.68
Precedente Chiudi:
$34.05
Aprire:
$33.92
Volume 24 ore:
106.23K
Relative Volume:
0.28
Capitalizzazione di mercato:
$2.81B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-12.00%
1M Prestazione:
-10.46%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Heartflow Inc Stock (HTFL) Company Profile
Nome
Heartflow Inc
Settore
Industria
Telefono
650-241-1221
Indirizzo
331 E EVELYN AVENUE, MOUNTAIN VIEW
Confronta HTFL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
HTFL
Heartflow Inc
|
33.68 | 2.84B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
291.12 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
86.49 | 15.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.12 | 12.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.26 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.02 | 7.08B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-02 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | JP Morgan | Overweight |
| 2025-09-02 | Iniziato | Morgan Stanley | Equal-Weight |
| 2025-09-02 | Iniziato | Piper Sandler | Overweight |
| 2025-09-02 | Iniziato | Stifel | Buy |
Heartflow Inc Borsa (HTFL) Ultime notizie
Strong Investor Reception of IPO Boosted Heartflow (HTFL) in Q3 - Insider Monkey
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025 - MarketScreener
Heartflow (NASDAQ: HTFL) to present late-breaking Plaque Analysis AHA 2025: 7 abstracts - Stock Titan
Heartflow, Inc. (NASDAQ:HTFL) Sees Significant Decline in Short Interest - MarketBeat
HeartFlow’s Innovative Study on Cardiac Risk in NFL Alumni: A Potential Game-Changer - TipRanks
HeartFlow’s COMPLETE Study: A New Frontier in Coronary Artery Disease Evaluation - TipRanks
FDA Clears Next-Gen Heartflow Plaque Analysis Platform - Medical Product Outsourcing
Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 - The Manila Times
Heartflow (NASDAQ:HTFL) Trading 5.5% HigherWhat's Next? - MarketBeat
Heartflow Introduces PCI Planning Tool - Diagnostic and Interventional Cardiology
Assessing HeartFlow After a 14% Weekly Surge and Expanding Tech Partnerships - Yahoo Finance
Heartflow (NASDAQ:HTFL) Sets New 52-Week HighShould You Buy? - MarketBeat
Heartflow introduces Heartflow PCI Navigator - TipRanks
New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning - The Manila Times
Heartflow (NASDAQ: HTFL) unveils PCI Navigator for 3D planning; NAVIGATE-PCI enroll 2,500 - Stock Titan
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Technical Analysis of Heartflow, Inc. (NASDAQ:HTFL) - TradingView
ETFs Investing in Heartflow, Inc. Stocks - TradingView
HTFL Stock Price and Chart — NASDAQ:HTFL - TradingView
Heartflow (NASDAQ:HTFL) Sets New 12-Month HighShould You Buy? - MarketBeat
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis - Yahoo Finance
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Why HeartFlow Stock Rocketed 14% Higher Today - MSN
Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive
Cigna will cover CT imaging artificial intelligence software nationwide - Radiology Business
HTFL Crosses Above Average Analyst Target - Nasdaq
FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech
Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛
Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace
Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com Nigeria
Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener
Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener
Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus
FDA Clears Heartflow Coronary Plaque Technology - MarketScreener
Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks
95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan
Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat
Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria
Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat
Heartflow price target raised to $39 from $35 at Canaccord - TipRanks
Heartflow (NASDAQ:HTFL) Announces Quarterly Earnings Results - MarketBeat
AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN
Heartflow Inc Azioni (HTFL) Dati Finanziari
Non sono disponibili dati finanziari per Heartflow Inc (HTFL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):